Kofarest AL 2.5 mg/30 mg Syrup
By Kofarest AL
Rx
60ml Syrup in a Bottle

Composition
Levocetirizine(2.5mg) + Ambroxol(30mg)

Manufacturer - Centaur Pharmaceuticals Pvt Ltd
CENTAUR HOUSE, Near Grand Hyatt, Vakola ,Santacruz – East, Mumbai – 400 055, India.

Expires on or after
October, 2025

liver
Kofarest AL 2.5 mg/30 mg Syrup needs to be used carefully in individuals with liver problems. It may require adjusting the dosage for these patients. It is crucial to seek advice from your doctor before using the syrup.

kidney
Kofarest AL 2.5 mg/30 mg Syrup requires caution in patients with kidney disease. Dose adjustment may be necessary, and it is not advised for those with severe kidney disease. Please consult with your doctor before using Kofarest AL 2.5 mg/30 mg Syrup.

alcohol
When taking Kofarest AL 2.5 mg/30 mg Syrup, be cautious about alcohol as it can lead to increased drowsiness. It is necessary to stay vigilant on the combination to ensure safety, especially during pregnancy.

driving
When using Kofarest AL 2.5 mg/30 mg Syrup, be cautious while driving as it may reduce alertness, cause vision impairment, and lead to drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Kofarest AL 2.5 mg/30 mg Syrup may not be safe to use during pregnancy. Studies on animals have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it. Please consult your doctor before using.

breastfeeding
It is better to consult your doctor before using Kofarest AL 2.5 mg/30 mg Syrup during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹46.23
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024